Evidence map›Paper›PMID 42115538›Full record

ArticleThe AAPS journal2026

In-depth Characterization of Photo-Stressed Antibody-Drug Conjugates by Mass Spectrometry.

Xiao Pan, Yimeng Zhao, Shukun Luo, Joshua Bulos, Jieqiang Zhong, Yuetian Yan, Zhijie Wu, Yue Su, Sisi Zhang, Shunhai Wang and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xiao PanAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0002-4444-8275
Yimeng ZhaoAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA. yimeng.zhao@regeneron.com.ORCID 0009-0004-7199-6383
Shukun LuoDrug Product Development and Technology, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0002-2766-3125
Joshua BulosDrug Product Development and Technology, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0009-0001-1480-3694
Jieqiang ZhongAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0002-0906-695X
Yuetian YanAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0001-9032-7880
Zhijie WuAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0002-9981-8114
Yue SuAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0009-0004-1523-6283
Sisi ZhangAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0009-0008-5525-1583
Shunhai WangAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0003-4055-2187
Hui XiaoAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0001-9489-054X
Wenhua WangDrug Product Development and Technology, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0009-0002-6653-2002
Dingjiang LiuDrug Product Development and Technology, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0002-8665-2426
Ning LiAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.ORCID 0000-0001-6750-4308
Haibo QiuAnalytical and Biological Mass Spectrometry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA. haibo.qiu@regeneron.com.ORCID 0000-0002-8449-4233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Camptothecin (CPT)-based antibody-drug conjugates (ADCs) have become popular oncology biotherapeutics that integrate the targeted specificity of monoclonal antibodies (mAbs) with camptothecin and its derivatives. Because mAbs are vulnerable to photodegradation and the light-absorbing characteristics of camptothecin, understanding the effects of light exposure on CPT-based ADCs is critical to ensure product quality, efficacy, and safety. Herein, we harnessed the capabilities of advanced liquid chromatography-mass spectrometry (LC-MS) to perform in-depth molecular-level characterization of photo-stressed antibodies conjugated with a camptothecin derivative payload, deruxtecan (DXd). Peptide mapping via LC-MS/MS revealed significant oxidative modifications in methionine, tryptophan, and histidine residues, and degradation of the linker payload in the photo-stressed ADC molecules. Native SEC-MS with post-column denaturation was conducted to further characterize the covalent nature of high molecular weight species formed under photo stress and provide insights into aggregation mechanisms. Additionally, coupling LC to high-resolution MS enabled the identification and quantitation of degradants from excipients and the linker payload, thus providing a comprehensive understanding of light exposure effects on DXd ADCs. Application of these LC-MS based assays to evaluate the effects of various formulations on photostability revealed that histidine and methionine act as oxidative scavengers that protect ADC molecules against light-induced degradation. This study highlights the utility of LC-MS methods in the comprehensive characterization of photo-stressed CPT-based ADCs, and provides valuable insights for process optimization, formulation development, and storage condition recommendations.

Indexed as

Antibodies, MonoclonalCamptothecinImmunoconjugatesLightLiquid Chromatography-Mass SpectrometryPeptide MappingPhotolysisTandem Mass SpectrometryAntibodies, MonoclonalCamptothecinImmunoconjugatesantibody–drug conjugatesexcipient degradationLC–MSphotostabilitypost-translational modifications

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.